Appendix 2 of Grossman, Mol Vis 2017; 23:561-571.


Appendix 2. Dose dependent reduction in hepatic FB mRNA after SC administration of FB ASOs.

C57BL/6J mice were treated for 6 weeks with the indicated weekly doses of FB ASO via subcutaneous injection (n=4 per group). Results represent mean ± SEM. To access the data, click or select the words “Appendix 2”.